New drug EI1071 tested for safety in healthy people
Knowledge-focused
Completed
This early-phase trial tested the safety and tolerability of a new drug called EI1071 in 58 healthy volunteers. Participants received either single or multiple doses of the drug or a placebo. The study aimed to understand how the body processes the drug and whether it causes any …
Phase: PHASE1 • Sponsor: Elixiron Immunotherapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC